In subsequent studies, the angiogenic potential of IL-1 was confirmed by Elaraj et al., who observed high expression of IL-1 mRNA in more than half of all tested metastatic human tumor specimens, including non-small-cell lung carcinoma, colorectal adenocarcinoma, and melanoma tumor samples. This evidence concerns the gene IL1A and colorectal adenocarcinoma.